Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | INSM | INSMED INC | Healthcare | 10,250.0 | $1.7M | 0.07% | -38K | -78.9% | $163.52 | -35.0% |
| 22 | CGON | CG ONCOLOGY INC | Healthcare | 20,000.0 | $1.4M | 0.06% | -150K | -88.2% | $67.68 | -5.1% |
| 23 | NEO | NEOGENOMICS INC | Healthcare | 175,000.0 | $1.3M | 0.05% | -253K | -59.1% | $7.42 | +24.4% |
| 24 | COGT | COGENT BIOSCIENCES INC | Healthcare | 10,000.0 | $385K | 0.02% | -110K | -91.7% | $38.49 | -15.1% |
| 25 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 10,000.0 | $383K | 0.02% | -115K | -92.0% | $38.30 | -15.2% |
| 26 | STAA | STAAR SURGICAL CO | Healthcare | 20,000.0 | $374K | 0.01% | -5K | -20.0% | $18.70 | +73.6% |
| 27 | ANAB | ANAPTYSBIO INC | Healthcare | 6,000.0 | $333K | 0.01% | -129K | -95.6% | $55.46 | +7.7% |
| 28 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 10,000.0 | $270K | 0.01% | -290K | -96.7% | $27.04 | +7.3% |
| 29 | — | ZYMEWORKS INC | — | 10,000.0 | $250K | 0.01% | -90K | -90.0% | $25.04 | — |
| 30 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 5,000.0 | $245K | 0.01% | -185K | -97.4% | $49.05 | +23.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%